CSL Aktie

 

MONTRÉAL, Aug. 20, 2025 /PRNewswire/ -- The CSL Group ("CSL") has deployed its newest addition to the fleet, MV CSL Flexvik, to support marine construction and aggregate logistics across Europe. This 18,003 DWT hybrid self-loading/unloading vessel has been engineered to deliver maximum......

Macquarie forecasts a big rebound is coming for CSL shares. But why? The post Why Macquarie says the HUGE sell-off in CSL shares is way overdone appeared first on The Motley Fool Australia....

Bell Potter has given its verdict on the fallen biotech star. The post Are CSL shares a buy after the brutal selloff? appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CSL CEO and Managing Director Paul McKenzie says the time is right to spin off its Seqirus business as vaccine demand grows and "fatigue" fades in the US, especially among the ageing population. The Australian biotech giant's shares plunged the most in 23 years after it reported disappointing earnings. (Source: Bloomberg)...

Aussie success story CSL is battling the US president's threat against big pharma and the vaccine scepticism of his health tsar, but that's not why its shares plunged as the company purges thousands of staff....

Good Afternoon and welcome to HotCopper's Market Close for Tuesday 19th of August,…...

With more than seven million users on the HotCopper forums, every discussion…...

These shares are having a difficult time on Tuesday. But why? The post Why CSL, HMC Capital, Reliance, and Suncorp shares are sinking today appeared first on The Motley Fool Australia....

It's out with the big ASX 200 bank and in with the healthcare blue-chip. The post Why are wealthy investors offloading CBA shares and buying up CSL? appeared first on The Motley Fool Australia....

Earnings day hasn't quite been a shining one for CSL Ltd (ASX:CSL),…...

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Major strategic initiatives, including demerger, to transform CSL MELBOURNE, Aug. 19, 2025 /PRNewswire/ -- Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant currency basis.......

CSL delivered solid FY25 growth, announced a Seqirus demerger, and plans a fresh share buyback to support investors. The post CSL FY25 earnings: Revenue grows, Seqirus demerger ahead appeared first on The Motley Fool Australia....

Australian biotech giant CSL Ltd. said it will spin off its Seqirus vaccine business into a separately listed company, as it reported full-year profit that was slightly higher than expected....

CSL prices $1B in senior notes to fund debt repayment, capital spending, buybacks and acquisitions....

PAAS, CSL and DHT announce dividend hikes, offering income stability as markets face tariff-driven volatility and inflation concerns....

Two leading experts deliver their verdicts for CSL shares. The post Should you buy the rebound in CSL shares today? appeared first on The Motley Fool Australia....

PAAS, CSL and DHT announce fresh dividend hikes, offering steady income streams amid renewed market volatility....

CANBERA (dpa-AFX) - CSL Ltd. (CSL.AX) Friday said Health Canada has approved Andembry for the treatment of hereditary angioedema (HAE) in patients aged 12 years and older.HAE is a genetic disorder......